A5089500153- Colorectal Cancer Screening and Detection
- Gastric Cancer Management and Outcomes
- Cancer Diagnosis and Treatment
- Esophageal Cancer Research and Treatment
- Diverticular Disease and Complications
- Bone health and treatments
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Colorectal Cancer Treatments and Studies
- Mycobacterium research and diagnosis
- Management of metastatic bone disease
Nankai University
2023-2025
Tianjin People's Hospital
2023-2024
Abstract Background Compliance with colonoscopy among elderly individuals participating in colorectal cancer (CRC) screening programs is unsatisfactory, despite a high detection rate of bowel‐related diseases. In this study, our aim was to analyze the impact risk factors on trends compliance and rates high‐risk aged 60–74. Methods A retrospective study conducted 60–74 2021 CRC program Tianjin, China. Logistic regression analyses, including both univariate multivariate were performed explore...
Colonoscopy is an important colorectal cancer (CRC) screening modality; however, not all high-risk groups identified by fecal immunochemical test (FIT) and/or factor questionnaire (HRFQ) undergo colonoscopy in time. The impact of delays on CRC detection among populations remains poorly understood, warranting further clarification.A retrospective study was conducted population Tianjin program. According to the results after HRFQ and FIT, patients were classified into CRC, advanced adenoma,...
Abstract Background Local recurrence after surgery and radiochemotherapy seriously affects the prognosis of locally advanced rectal cancer (LARC) patients. Studies on molecular markers related to sensitivity cancers have been widely carried out, which might provide valued information for clinicians carry out individual treatment. Aim To find potential biomarkers tumors predicting postoperative recurrence. Methods In this study, LARC patients undergoing concurrent were enrolled. We focused...